Zoë Blake

575 total citations
18 papers, 265 citations indexed

About

Zoë Blake is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Zoë Blake has authored 18 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 6 papers in Genetics. Recurrent topics in Zoë Blake's work include Prostate Cancer Diagnosis and Treatment (5 papers), Virus-based gene therapy research (4 papers) and Renal cell carcinoma treatment (4 papers). Zoë Blake is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (5 papers), Virus-based gene therapy research (4 papers) and Renal cell carcinoma treatment (4 papers). Zoë Blake collaborates with scholars based in United States, Singapore and United Kingdom. Zoë Blake's co-authors include Yvonne M. Saenger, Bret Taback, Robyn D. Gartrell, Marc Matrana, Adrian G. Sacher, Claud Grigg, Alessandro Rizzo, Matteo Santoni, Madhav KC and Ugo De Giorgi and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Obstetrics and Gynecology and Journal of Investigative Dermatology.

In The Last Decade

Zoë Blake

16 papers receiving 263 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zoë Blake United States 8 161 83 80 54 52 18 265
Zena Salih United Kingdom 7 178 1.1× 41 0.5× 54 0.7× 107 2.0× 37 0.7× 20 309
Nicholas D’Cunha United States 9 151 0.9× 37 0.4× 85 1.1× 103 1.9× 28 0.5× 32 282
Simona Pigozzi Italy 9 121 0.8× 51 0.6× 101 1.3× 61 1.1× 16 0.3× 24 320
Lisa Boselli France 10 281 1.7× 83 1.0× 72 0.9× 154 2.9× 19 0.4× 13 383
Katherine A. Waugh United States 7 215 1.3× 49 0.6× 68 0.8× 248 4.6× 38 0.7× 16 423
Lorna Grove United Kingdom 9 150 0.9× 94 1.1× 72 0.9× 27 0.5× 75 1.4× 15 343
Sho Sato Japan 12 157 1.0× 67 0.8× 117 1.5× 101 1.9× 19 0.4× 32 411
Hilda Haynes United States 11 207 1.3× 82 1.0× 128 1.6× 37 0.7× 98 1.9× 21 384
Mikiya Ishihara Japan 8 146 0.9× 36 0.4× 65 0.8× 100 1.9× 29 0.6× 35 234
Shweta S. Chavan United States 9 142 0.9× 59 0.7× 139 1.7× 65 1.2× 16 0.3× 21 320

Countries citing papers authored by Zoë Blake

Since Specialization
Citations

This map shows the geographic impact of Zoë Blake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zoë Blake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zoë Blake more than expected).

Fields of papers citing papers by Zoë Blake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zoë Blake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zoë Blake. The network helps show where Zoë Blake may publish in the future.

Co-authorship network of co-authors of Zoë Blake

This figure shows the co-authorship network connecting the top 25 collaborators of Zoë Blake. A scholar is included among the top collaborators of Zoë Blake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zoë Blake. Zoë Blake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Pinto, Cathy Anne, Julie Fox, Ananya Roy, et al.. (2025). Longitudinal Evaluation of Clear-cell Renal Cell Carcinoma in von Hippel-Lindau Disease. European Urology. 88(1). 56–63. 1 indexed citations
3.
Harmon, Stephanie A., Jesse Tetreault, Enis C. Yılmaz, et al.. (2024). Automated Detection and Grading of Extraprostatic Extension of Prostate Cancer at MRI via Cascaded Deep Learning and Random Forest Classification. Academic Radiology. 31(10). 4096–4106. 11 indexed citations
4.
Pinto, Peter A., Sheng Xu, Patrick T. Gomella, et al.. (2023). A Novel Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy Technique Using Transperineal Ultrasound: An Initial Experience. Urology. 181. 76–83.
5.
Schmidt, Laura S., Cathy D. Vocke, Christopher J. Ricketts, et al.. (2023). PRDM10 RCC: A Birt-Hogg-Dubé-like Syndrome Associated With Lipoma and Highly Penetrant, Aggressive Renal Tumors Morphologically Resembling Type 2 Papillary Renal Cell Carcinoma. Urology. 179. 58–70. 10 indexed citations
6.
Harmon, Stephanie A., Mason J. Belue, Enis C. Yılmaz, et al.. (2023). Comparison of MRI-Based Staging and Pathologic Staging for Predicting Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy. American Journal of Roentgenology. 221(6). 773–787. 9 indexed citations
7.
Belue, Mason J., Zoë Blake, Enis C. Yılmaz, et al.. (2023). Is prostatic adenocarcinoma with cribriform architecture more difficult to detect on prostate MRI?. The Prostate. 83(16). 1519–1528. 3 indexed citations
8.
Santoni, Matteo, Francesco Massari, Marc Matrana, et al.. (2022). Statin use improves the efficacy of nivolumab in patients with advanced renal cell carcinoma. European Journal of Cancer. 172. 191–198. 15 indexed citations
9.
Gartrell, Robyn D., Zoë Blake, Emanuelle M. Rizk, et al.. (2022). Combination immunotherapy including OncoVEXmGMCSF creates a favorable tumor immune micro-environment in transgenic BRAF murine melanoma. Cancer Immunology Immunotherapy. 71(8). 1837–1849. 4 indexed citations
10.
Mollica, Veronica, Matteo Santoni, Marc Matrana, et al.. (2021). Concomitant Proton Pump Inhibitors and Outcome of Patients Treated with Nivolumab Alone or Plus Ipilimumab for Advanced Renal Cell Carcinoma. Targeted Oncology. 17(1). 61–68. 68 indexed citations
11.
Shuffle, Eric, et al.. (2021). 357 Digital medicine to increase compliance for hypertensive disorders of pregnancy: a retrospective cohort study. American Journal of Obstetrics and Gynecology. 224(2). S233–S233. 2 indexed citations
12.
KC, Madhav, et al.. (2021). Timing of steroid initiation and response rates to immune checkpoint inhibitors in metastatic cancer. Journal for ImmunoTherapy of Cancer. 9(7). e002261–e002261. 55 indexed citations
13.
Blake, Zoë, et al.. (2020). Impact of body mass index on survival rates in patients receiving immune checkpoint inhibitors.. Journal of Clinical Oncology. 38(15_suppl). e15108–e15108. 3 indexed citations
14.
Blake, Zoë, et al.. (2020). Cumulative steroid doses and response rates to immune checkpoint inhibitors in metastatic cancer.. Journal of Clinical Oncology. 38(15_suppl). e15133–e15133. 1 indexed citations
15.
Gartrell, Robyn D., Zoë Blake, Douglas K. Marks, et al.. (2018). 1192 Distinguishing melanophages from melanoma in metastatic melanoma treated with t-vec: A clinical application of quantitative multiplex immunofluorescence. Journal of Investigative Dermatology. 138(5). S202–S202. 2 indexed citations
16.
Blake, Zoë, Douglas K. Marks, Robyn D. Gartrell, et al.. (2018). Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition. Journal for ImmunoTherapy of Cancer. 6(1). 25–25. 29 indexed citations
17.
Gartrell, Robyn D., Zoë Blake, Rolando Pérez‐Lorenzo, et al.. (2018). Effect of combination immunotherapy on tumor growth, survival, and intratumoral immune infiltration in transgenic murine model of melanoma.. Journal of Clinical Oncology. 36(15_suppl). e21610–e21610. 1 indexed citations
18.
Grigg, Claud, Zoë Blake, Robyn D. Gartrell, et al.. (2016). Talimogene laherparepvec (T-Vec) for the treatment of melanoma and other cancers. Seminars in Oncology. 43(6). 638–646. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zena Salih Breakdown of academic impact, for papers by Nicholas D’Cunha Breakdown of academic impact, for papers by Simona Pigozzi Breakdown of academic impact, for papers by Lisa Boselli Breakdown of academic impact, for papers by Katherine A. Waugh Breakdown of academic impact, for papers by Lorna Grove Breakdown of academic impact, for papers by Sho Sato Breakdown of academic impact, for papers by Hilda Haynes Breakdown of academic impact, for papers by Mikiya Ishihara Breakdown of academic impact, for papers by Shweta S. Chavan
Rankless by CCL
2026